| COVID-19: coagulopathy, risk of thrombosis, and the rationale for anticoagulation W Miesbach, M Makris Clinical and applied thrombosis/hemostasis 26, 1076029620938149, 2020 | 497 | 2020 |
| Gene therapy with adeno-associated virus vector 5–human factor IX in adults with hemophilia B W Miesbach, K Meijer, M Coppens, P Kampmann, R Klamroth, ... Blood, The Journal of the American Society of Hematology 131 (9), 1022-1031, 2018 | 313 | 2018 |
| Prognostic factors for remission of and survival in acquired hemophilia A (AHA): results from the GTH-AH 01/2010 study A Tiede, R Klamroth, RE Scharf, RU Trappe, K Holstein, A Huth-Kühne, ... Blood, The Journal of the American Society of Hematology 125 (7), 1091-1097, 2015 | 253 | 2015 |
| Safety and pharmacokinetics of anti‐TFPI antibody (concizumab) in healthy volunteers and patients with hemophilia: a randomized first human dose trial P Chowdary, S Lethagen, U Friedrich, B Brand, C Hay, FA Karim, ... Journal of Thrombosis and Haemostasis 13 (5), 743-754, 2015 | 241 | 2015 |
| Vitamin D: an instrumental factor in the anti-phospholipid syndrome by inhibition of tissue factor expression N Agmon-Levin, M Blank, G Zandman-Goddard, H Orbach, PL Meroni, ... Annals of the Rheumatic Diseases 70 (1), 145-150, 2011 | 179 | 2011 |
| Comparison of the fibrinogen Clauss assay and the fibrinogen PT derived method in patients with dysfibrinogenemia W Miesbach, J Schenk, S Alesci, E Lindhoff-Last Thrombosis research 126 (6), e428-e433, 2010 | 143 | 2010 |
| Molecular basis of antithrombin deficiency B Luxembourg, D Delev, C Geisen, M Spannagl, M Krause, W Miesbach, ... Thrombosis and haemostasis 105 (04), 635-646, 2011 | 121 | 2011 |
| Deep vein thrombosis of the upper extremity: a systematic review J Heil, W Miesbach, T Vogl, WO Bechstein, A Reinisch Deutsches Ärzteblatt International 114 (14), 244, 2017 | 119 | 2017 |
| Gene therapy with etranacogene dezaparvovec for hemophilia B SW Pipe, FWG Leebeek, M Recht, NS Key, G Castaman, W Miesbach, ... New England Journal of Medicine 388 (8), 706-718, 2023 | 118 | 2023 |
| The course of ADAMTS‐13 activity and inhibitor titre in the treatment of thrombotic thrombocytopenic purpura with plasma exchange and vincristine M Böhm, C Betz, W Miesbach, M Krause, C von Auer, H Geiger, I Scharrer British journal of haematology 129 (5), 644-652, 2005 | 114 | 2005 |
| Genome-wide spatial expression profiling in formalin-fixed tissues EG Villacampa, L Larsson, R Mirzazadeh, L Kvastad, A Andersson, ... Cell Genomics 1 (3), 2021 | 113 | 2021 |
| Pathological role of angiotensin II in severe COVID-19 W Miesbach TH open 4 (02), e138-e144, 2020 | 111 | 2020 |
| Etranacogene dezaparvovec (AMT-061 phase 2b): normal/near normal FIX activity and bleed cessation in hemophilia B A Von Drygalski, A Giermasz, G Castaman, NS Key, S Lattimore, ... Blood advances 3 (21), 3241-3247, 2019 | 111 | 2019 |
| Real-world data confirm the effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpura LA Völker, J Kaufeld, W Miesbach, S Brähler, M Reinhardt, L Kühne, ... Blood advances 4 (13), 3085-3092, 2020 | 98 | 2020 |
| Gene therapy for hemophilia: a review on clinical benefit, limitations, and remaining issues FWG Leebeek, W Miesbach Blood, The Journal of the American Society of Hematology 138 (11), 923-931, 2021 | 95 | 2021 |
| New direct oral anticoagulants–current therapeutic options and treatment recommendations for bleeding complications W Miesbach, E Seifried Thrombosis and haemostasis 108 (10), 625-632, 2012 | 92 | 2012 |
| Comorbidities and bleeding pattern in elderly haemophilia A patients W Miesbach, S Alesci, S Krekeler, E Seifried Haemophilia 15 (4), 894-899, 2009 | 85 | 2009 |
| Association between phenotype and genotype in carriers of haemophilia A W Miesbach, S Alesci, C Geisen, J Oldenburg Haemophilia 17 (2), 246-251, 2011 | 75 | 2011 |
| How to discuss gene therapy for haemophilia? A patient and physician perspective W Miesbach, B O’Mahony, NS Key, M Makris Haemophilia 25 (4), 545-557, 2019 | 74 | 2019 |
| Thrombotic manifestations of the antiphospholipid syndrome in patients with malignancies W Miesbach, I Scharrer, R Asherson Clinical rheumatology 25, 840-844, 2006 | 74 | 2006 |
